Prophylaxis of migraine with aura: a place for acetylsalicylic acid by LT Savi et al.
POSTER PRESENTATION Open Access
Prophylaxis of migraine with aura: a place
for acetylsalicylic acid
LT Savi1*, V Condello1, F Bert2, L Pinessi3
From The European Headache and Migraine Trust International Congress
London, UK. 20-23 September 2012
Aim
Aim of our study was to assess the efficacy and tolerability
of Acetylsalicylic acid (ASA) in migraine with aura (MA)
management, in a sample afferent to the Headache Centre
of San Giovanni Battista University-Hospital of Torino.
Materials and methods
We analyzed the medical records of 196 patients affering
consecutively to our Centre between 1995 and 2007 and
receiving a prophylactic treatment, dividing them in two
groups: the ones receiving ASA (90) and those who were
treated with other therapies (106). Primary endpoint was
to evaluate the improvement in MA crisis frequency in the
two groups. A binary logistic regression model was used to
identify possible factors associated with the positive
response to treatment.
Results
The mean age was 32.1 (±9.9) in ASA group and 36.8
(±14.9) in no-ASA group. Positive response to treatment
(measured as a reduction of at least the 50% of crisis with
aura) was reported by 85.6% of patients in the ASA group
and 51.9% in the control group (p< 0.001). Multivariate
analysis showed, as only variable related with a positive
response to treatment, the group (ASA Group: OR 6.26,
p= 0.006), while there were no relationships with gender,
age or typology of aura.
Discussion
In the past, other studies compared the effectiveness of
ASA in migraine versus other prophylactic therapies,
but they often considered very small samples, mixing
MA and migraine without aura (MoA) together. In
those setting ASA appeared to be mildly effective. Our
results show a large positive response to the treatment
with Acetylsalicylic acid, whose probability of success
was about six times greater than the one associated with
other therapies.
Conclusions
According to our results, asa is not only effective in the
majority of MA cases, but the response is usually evident
in a short time. A double blind study with a larger sample
is needed to ascertain these findings.
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